
The Human Upgrade: Biohacking for Longevity & Performance Viruses: The Ultimate Gene Therapy Machines – Liz Parrish : 682
7 snips
Mar 31, 2020 Liz Parrish, Founder and CEO of BioViva Sciences, is pioneering the use of gene therapy to extend healthy lifespans. She shares her experience as the first person to undergo dual gene therapies for aging and discusses how viruses can act as effective delivery systems for genes. The conversation dives into the ethical challenges of genetic engineering, the role of mitochondria in aging, and the potential of gene therapies to replace traditional medicine. With insights on enhancing athletic performance and the future of biohacking, it's a glimpse into the cutting edge of medical science.
AI Snips
Chapters
Books
Transcript
Episode notes
Gap Between Research and Treatment
- Academic research often concludes with "more research is needed", hindering translation to patients.
- Doctors face a dilemma: adhering to the Hippocratic Oath or using potentially effective but unproven therapies.
Importance of Reproducibility
- Prioritize reproducibility across multiple labs when considering new technologies.
- Ensure data integrity to prevent harm from potentially flawed research.
Liz Parrish's Gene Therapies
- Liz Parrish underwent two gene therapies: telomerase induction to lengthen telomeres and follistatin to block myostatin.
- Telomere shortening correlates with age-related diseases, while myostatin inhibits muscle growth.







